GenSci144 Tablets Phase I Clinical Trial

Inclusion Criteria: * Healthy men and women aged 18 to 45, with at least 3 people of the same gender in each group. * BMI 19\~26 kg/m², men weigh ≥50 kg, women ≥45 kg. * Voluntarily sign the informed consent form, fully aware of the research risks and procedures. * Use reliable contraception for 3 months after the last dose, no plans for pregnancy or sperm/egg donation. Exclusion Criteria: * A family history of sudden death and serious neuropsychiatric disorders. * Major underlying conditions like gastrointestinal absorption problems, chronic liver, kidney, heart, and endocrine diseases. * Liver function, kidney function with eGFR\<90, abnormal QTc interval, positive for various infectious diseases. * Drug allergies, drug abuse, recent participation in other clinical trials. * Drinking alcohol, smoking, taking grapefruit/amino acid supplements, and having a chaotic routine during the screening period. * Pregnant or breastfeeding women, people who can't tolerate blood draws or get faint from needles.